Extending the specificity of the DAT reagents in specific clinical situations

  • For the investigation of those clinical situations where the presence of hemolysis has been established or is suspected, to distinguish immune from nonimmune hemolytic anemia
  • For the investigation of :

Ø  Autoimmune hemolytic anemia (AIHA)

Ø  Hemolytic disease of the fetus and neonate (HDFN)

Ø  Hemolytic transfusion reactions (HTR)

Ø  Hemolytic reactions related to allogeneic stem cell transplant or solid organ transplant

Ø  Drug-induced immune hemolytic anemia (DIHA)